This too shall pass: Standardized Gastrografin protocol for partial small bowel obstruction

One of the most common reasons for admission to a surgical service is for a partial small bowel obstruction. There is considerable variation in management. Several studies suggest that the use of diatrizoate (Gastrografin), a hyperosmolar contrast agent, can be helpful as a diagnostic agent as well...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of surgery 2019-06, Vol.217 (6), p.1016-1018
Main Authors: Long, S., Emigh, B., Wolf, J.S., Byrne, C., Coopwood, T.B., Aydelotte, J.
Format: Article
Language:English
Subjects:
Abdomen
Adhesives
Adolescent
Adult
Aged
Aged, 80 and over
Algorithms
Clinical Protocols
Communities
Contrast agents
Contrast Media
Diagnosis
Diagnostic systems
Diatrizoate Meglumine - therapeutic use
Female
Gastrointestinal Agents - therapeutic use
Hospitals
Humans
Intervention
Intestinal obstruction
Intestinal Obstruction - diagnostic imaging
Intestinal Obstruction - drug therapy
Intestinal Obstruction - surgery
Intestine, Small - diagnostic imaging
Intestine, Small - surgery
Length of Stay - statistics & numerical data
Male
Middle Aged
Osmotic pressure
Patients
Physicians
Retrospective Studies
Small intestine
Surgeons
Surgery
Treatment Outcome
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:One of the most common reasons for admission to a surgical service is for a partial small bowel obstruction. There is considerable variation in management. Several studies suggest that the use of diatrizoate (Gastrografin), a hyperosmolar contrast agent, can be helpful as a diagnostic agent as well as possibly therapeutic, reducing the need for operative intervention. There is a paucity of data on the use of Gastrografin in the community setting. We hypothesized that this standardized algorithm of Gastrografin administration would decrease the need for surgery and shorten a patient's length of stay, even outside the confines of a regulated clinical trial. We performed a retrospective review of all patients admitted to two major hospitals in our network with the diagnosis of partial small bowel obstruction. Patients were excluded if they were admitted within thirty days of bowel surgery or if they were
ISSN:0002-9610
1879-1883
DOI:10.1016/j.amjsurg.2018.12.063